LI
ICPT

LMCG Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

LMCG Investments’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$6.79M Buy
40,971
+8,690
+27% +$1.91M 0.15% 260
2015
Q2 		$7.79M Buy
32,281
+707
+2% +$188K 0.17% 240
2015
Q1 		$8.9M Buy
31,574
+15,700
+99% +$3.4M 0.19% 222
2014
Q4 		$2.48M Buy
15,874
+5,134
+48% +$948K 0.05% 325
2014
Q3 		$2.54M Buy
10,740
+4,360
+68% +$1.11M 0.06% 317
2014
Q2 		$1.51M Buy
6,380
+3,667
+135% +$966K 0.03% 366
2014
Q1 		$895K Sell
2,713
-10,326
-79% -$3.48M 0.02% 391
2013
Q4 		$890K Buy
+13,039
New +$753K 0.02% 385

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

LMCG Investments's ICPT Position: Q3 2015 in Review

LMCG Investments increased its Intercept Pharmaceuticals, Inc. (ICPT) stake by 27% in Q3 2015, buying an estimated $1.91M and bringing the position to 40,971 shares worth $6.79M. The position accounts for 0.15% of the portfolio, ranked #260.

LMCG Investments first reported a position in ICPT in Q4 2013 and has held it in 8 quarters since. The position peaked at $8.9M in Q1 2015. 173 funds tracked by Wall St. Rank hold ICPT as of Q3 2015.

  • LMCG Investments held 40,971 shares of Intercept Pharmaceuticals, Inc. worth $6.79M as of Q3 2015.
  • LMCG Investments bought 8,690 Intercept Pharmaceuticals, Inc. shares in Q3 2015, an estimated $1.91M.
  • Intercept Pharmaceuticals, Inc. made up 0.15% of LMCG Investments's portfolio in Q3 2015, its #260 holding.
  • LMCG Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and has held it in 8 quarters since.
  • LMCG Investments's Intercept Pharmaceuticals, Inc. position peaked at $8.9M in Q1 2015.
  • 173 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.